A Trademark

Trademark Overview


On Tuesday, May 9, 2023, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 97928168. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 27, 2026. This trademark is owned by Athira Pharma, Inc.. The A trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical research and development; pharmaceutical drug development services

Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
a

General Information


Serial Number97928168
Word MarkA
Filing DateTuesday, May 9, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development; pharmaceutical drug development services
Goods and ServicesPrescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
Description of MarkThe mark consists of the a stylized letter "A" consisting of an incomplete star with a circle at the end of three of the points.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLEONABIO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98011
US

Party NameAthira Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98011
US

Party NameAthira Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011
US

Trademark Events


Event DateEvent Description
Friday, May 12, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 21, 2023ASSIGNED TO EXAMINER
Wednesday, December 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024SOU EXTENSION 1 FILED
Friday, April 12, 2024SOU EXTENSION 1 GRANTED
Saturday, April 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 4, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 4, 2025SOU EXTENSION 2 FILED
Wednesday, March 5, 2025SOU EXTENSION 2 GRANTED
Wednesday, March 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 13, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, August 13, 2025SOU EXTENSION 3 FILED
Wednesday, August 13, 2025SOU EXTENSION 3 GRANTED
Thursday, August 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2026AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 27, 2026ABANDONMENT - NO USE STATEMENT FILED
Monday, April 27, 2026ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED